| Financial Year |
March 31 2023 |
| Monetary Funds |
6,168,500,279.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
772,766,707.32 |
| Advances to Suppliers |
449,600,523.54 |
| Other Receivables |
396,401,193.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,230,464,457.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
225,346,302.38 |
| Total Current Assets |
12,221,108,422.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
494,324,139.41 |
| Investment Properties |
8,247,618.85 |
| Fixed Assetes |
2,312,165,119.04 |
| Under-construction Projects |
1,168,479,260.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,016,424,323.99 |
| R&D expenses |
-- |
| Goodwill |
2,000,722.67 |
| Long-Term Deferred and Prepaid Expenses |
178,350,588.12 |
| Deferred Income Tax Assets |
60,150,924.20 |
| Other Non-Current Assets |
858,585,664.71 |
| Sub-Total of Non-Current Assets |
7,034,819,442.56 |
| Total Assets |
19,255,927,865.28 |
| Short-Term Loans |
2,574,462,516.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
422,281,121.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,712,124.55 |
| Taxes Payable |
170,992,702.48 |
| Interest Payable |
-- |
| Dividend Payable |
592,732,316.80 |
| Other payables |
1,120,310,982.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
431,873,723.68 |
| Other Current Liabilities |
28,799,592.25 |
| Sub-Total of Current Liabilities |
4,896,377,236.71 |
| Long-term Loans |
1,267,673,546.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
72,178,752.36 |
| Deferred Income Tax Liabilities |
67,988,380.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,498,859,910.62 |
| Total Liabilities |
6,395,237,147.33 |
| Paid-In Capital(Or Share Stock) |
911,895,872.00 |
| Capital Surplus |
5,537,805,560.53 |
| Surplus Reserve |
213,315,388.65 |
| LESS:Treasury Stock |
26,507,875.00 |
| Undistributed Profits |
6,009,580,555.28 |
| Minority Stockholder's Interest |
264,375,553.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,596,315,164.58 |
| Owner's Equity（Stockholder's Equity） |
12,860,690,717.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,255,927,865.28 |
